Dataset Information


The Potential of Mesenchymal Stromal Cells in Neuroblastoma Therapy for Delivery of Anti-Cancer Agents and Hematopoietic Recovery.

ABSTRACT: Neuroblastoma is one of the most common pediatric cancers and a major cause of cancer-related death in infancy. Conventional therapies including high-dose chemotherapy, stem cell transplantation, and immunotherapy approach a limit in the treatment of high-risk neuroblastoma and prevention of relapse. In the last two decades, research unraveled a potential use of mesenchymal stromal cells in tumor therapy, as tumor-selective delivery vehicles for therapeutic compounds and oncolytic viruses and by means of supporting hematopoietic stem cell transplantation. Based on pre-clinical and clinical advances in neuroblastoma and other malignancies, we assess both the strong potential and the associated risks of using mesenchymal stromal cells in the therapy for neuroblastoma. Furthermore, we examine feasibility and safety aspects and discuss future directions for harnessing the advantageous properties of mesenchymal stromal cells for the advancement of therapy success.

PROVIDER: S-EPMC7996318 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7281487 | BioStudies
| S-EPMC3815584 | BioStudies
| S-EPMC8035760 | BioStudies
| S-EPMC5542197 | BioStudies
| S-EPMC3746216 | BioStudies
| S-EPMC5095779 | BioStudies
| S-EPMC2474517 | BioStudies
| S-EPMC3963485 | BioStudies
| S-EPMC4426094 | BioStudies
| S-EPMC5918153 | BioStudies